Information de reference pour ce titreAccession Number: | 00001832-201811000-00004.
|
Author: | Akbari, Ehsan a; Safari, Saeed b; Hatamabadi, Hamidreza c, *
|
Institution: | (a) Emergency Department, Imam Hosain Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran (b) Emergency Department, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran (c) Department of Emergency Medicine, Safety Promotion & Injury Prevention Research Center, Injury Prevention & Trauma Network, Shahid Beheshti University of Medical Sciences, Tehran, Iran
|
Title: | |
Source: | American Journal of Emergency Medicine. 36(11):1947-1950, November 2018.
|
Abstract: | Introduction: The debate on replacing coagulation factors and its effect on the final outcome of the patients with acute traumatic coagulopathy (ATC) in need of transfusion is still ongoing. Therefore, the present study is designed with the aim of comparing the outcome of patients with acute traumatic coagulopathies receiving fibrinogen and fresh frozen plasma (FFP).
Methods: In this quasi-experimental randomized controlled study, patients with severe blunt trauma (ISS > 16) and in need of packed cells transfusion were divided into 3 groups of receiving fibrinogen, receiving FFP, and control, and their final outcome was compared.
Results: 90 patients with the mean age of 33.16 +/- 16.32 years were randomly allocated to one of the 3 study groups (82.2% male). The 3 groups were similar regarding baseline characteristics. Patients receiving fibrinogen needed significantly less packed cells (p = 0.044) and intravenous fluid in the initial 24 h of hospitalization (p = 0.022). In addition, mortality rate (p = 0.029), need for admission to intensive care unit (p = 0.020) and duration of hospitalization (p = 0.045) were also lower in the group receiving fibrinogen. The number of sepsis cases in patients receiving fibrinogen and control group was lower than those who received FFP (p = 0.001). The number of multiple organ failure cases in patients receiving fibrinogen was about one fourth of the other 2 groups (p = 0.106), and a fewer number of them needed mechanical ventilation (p = 0.191). No case of venous thrombosis was detected in any of the 3 groups.
Conclusion: Multiple trauma patients in need of transfusion who received fibrinogen along with packed cells had significantly better outcomes regarding mortality, sepsis, need for admission to the intensive care unit, need for receiving packed cells, need for receiving intravenous fluids in the initial 24 h, and duration of hospitalization.
(C) 2018Elsevier, Inc.
|
Author Keywords: | Fibrinogen; Multiple trauma; Plasma; Blood coagulation disorders; Blood component transfusion.
|
References: | [1]. MacLeod JBA, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma Acute Care Surg. 2003;55(1):39-44.
[2]. Niles SE, McLaughlin DF, Perkins JG, Wade CE, Li Y, Spinella PC, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma Acute Care Surg. 2008;64(6):1459-1465.
[3]. Derakhshanfar H, Vafaei A, Tabatabaey A, Noori S. Prevalence and associated factors of acute traumatic coagulopathy; a cross sectional study. Emergency. 5. 1. 2017. e58.
[4]. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38(3):298-304.
[5]. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma Acute Care Surg. 2003;54(6):1127-1130.
[6]. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U. Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med. 2002;28:(s241-s7).
[7]. MacLeod JB, Lynn M, McKenney MG, Jeroukhimov I, Cohn SM. Predictors of mortality in trauma patients. Am Surg. 2004;70(9):805.
[8]. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10(7):1342-1351.
[9]. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81(2):360-365.
[10]. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266-273.
[11]. Ucar HI, Oc M, Tok M, Dogan OF, Oc B, Aydin A, et al. Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. Heart Surg Forum. 2007;10(5):E392-E396.
[12]. Bell SF, Rayment R, Collins PW, Collis R. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth. 2010;19(2):218-223.
[13]. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447-458.
[14]. Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma Acute Care Surg. 2009;66(1):41-49.
[15]. Inaba K, Karamanos E, Lustenberger T, Schochl H, Shulman I, Nelson J, et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg. 2013;216(2):290-297.
[16]. Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma Acute Care Surg. 2009;67(2):221-230.
[17]. Schlimp CJ, Ponschab M, Voelckel W, Treichl B, Maegele M, Schochl H. Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: a retrospective study. Scand J Trauma Resusc Emerg Med. 2016;24(1):29.
[18]. Curry N, Rourke C, Davenport R, Stanworth S, Brohi K. Fibrinogen replacement in trauma haemorrhage. Scand J Trauma Resusc Emerg Med. 2014;22(1):A5.
[19]. Wilhelmi M, Franke U, Cohnert T, Weber P, Kaukemuller J, Fischer S, et al. Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible? Eur J Cardiothorac Surg. 2001;19(5):657-661.
[20]. Menges T, Rupp D, van Lessen A, Hempelmann G. Measures for reducing the use of homologous blood. Effects on blood coagulation during total endoprosthesis. Anaesthesist. 1992;41(1):27-33.
[21]. Noddeland H, Tollofsrud S, Svennevig JL, Bentsen G, Brosstad F, Solheim BG. Universal solvent/detergent-treated fresh frozen plasma (Uniplas(R))-rationale and clinical properties. Thromb Res. 2002;107:(S33-S7).
[22]. Bochicchio GV, Napolitano L, Joshi M, Bochicchio K, Meyer W, Scalea TM. Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg. 2008;32(10):2185.
[23]. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL. Transfusion of the injured patient: proceed with caution. Shock. 2004;21(4):291-299.
[24]. Schlimp CJ, Voelckel W, Inaba K, Maegele M, Schochl H. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med. 2013;21(1):74.
[25]. Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg. 2007;109(2):166-171.
[26]. Duchesne JC, Hunt JP, Wahl G, Marr AB, Wang Y-Z, Weintraub SE, et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma Acute Care Surg. 2008;65(2):272-278.
|
Language: | English.
|
Document Type: | Original Contribution.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0735-6757
|
NLM Journal Code: | aa2, 8309942
|
DOI Number: | https://dx.doi.org/10.1016/j.aje...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|